Erleada Approved for Metastatic Castration-Sensitive Prostate Cancer
Erleada plus ADT achieved statistical significance in meeting both primary end points of OS and rPFS in the phase 3 TITAN study.
Prostate Cancer
Mushrooms May Lower Prostate Cancer Risk
In a study, Japanese men who ate mushrooms each week had lower risk for prostate cancer.
Adding Carboplatin to Cabazitaxel May Slow mCRPC Progression
In a phase 2 trial of men with metastatic castration-resistant prostate cancer, cabazitaxel plus carboplatin significantly prolonged progression-free survival compared with cabazitaxel alone.
Microbiome Analysis May Be a Feasible Diagnostic Test for Prostate Cancer
The microbiome could have a role in the diagnosis of PrCa.
Tertiary Gleason Pattern 5 Ups BCR Risk After Radical Prostatectomy
In a study of radical prostatectomy patients with Gleason score 7 prostate cancer, the risk for biochemical recurrence more than doubled in the presence of tertiary pattern 5 disease.
Knowing the Appropriateness of Running Noninferiority Trials in Oncology
Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either.
Adjusting the Risk Calculation for Biopsy-Detectable Prostate Cancer
Researchers sought to demonstrate how recalibration of risk stratification tools can improve accuracy and clinical decision making.
Rural Patients May Be Less Likely to Receive Treatment for Prostate Cancer
Simply living in a rural area made it less likely an individual with prostate cancer to receive treatment, with the exception of radiation.
Tapping Into the Therapeutic Expertise of High-Volume Cancer Centers
Researchers examine how patient outcomes could be affected if patients were to receive systemic drug treatment at dedicated cancer centers versus at community health systems.
Metastatic Site Predicts Death Risk in Advanced Prostate Cancer
A recent study of men with stage IV prostate cancer revealed that liver-only metastasis is associated with worse cancer-specific and overall survival than bone-only and lung-only metastasis
Next post in Prostate Cancer
